Lappe Mark
Insider CIK 1366074 · INBX Chief Executive Officer, Director · INBX Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-10-14 | 2026-10-14 | 100 | $85.76 | $8.6K | 170,000 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-10-14 | 2026-10-14 | 2,451 | $85.00 | $208.3K | 169,900 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-10-14 | 2026-10-14 | 2,449 | $84.07 | $205.9K | 167,449 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-10-14 | 2026-10-14 | 100 | $85.76 | $8.6K | 745,588 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-10-14 | 2026-10-14 | 2,470 | $85.00 | $209.9K | 745,488 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-10-14 | 2026-10-14 | 2,470 | $84.07 | $207.7K | 743,018 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-28 | 2026-09-28 | 3,000 | $101.70 | $305.1K | 740,548 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-28 | 2026-09-28 | 1,500 | $98.88 | $148.3K | 737,548 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-28 | 2026-09-28 | 3,000 | $101.70 | $305.1K | 740,548 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-28 | 2026-09-28 | 1,500 | $98.88 | $148.3K | 737,548 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-25 | 2026-09-28 | 2,176 | $99.60 | $216.7K | 736,048 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-25 | 2026-09-28 | 3,324 | $98.87 | $328.6K | 733,872 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-25 | 2026-09-28 | 2,176 | $99.60 | $216.7K | 736,048 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-25 | 2026-09-28 | 3,324 | $98.87 | $328.6K | 733,872 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-08 | 2026-09-08 | 1,100 | $107.12 | $117.8K | 719,148 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-08 | 2026-09-08 | 6,605 | $100.64 | $664.7K | 718,048 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-08 | 2026-09-08 | 5,895 | $99.29 | $585.3K | 711,443 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-08 | 2026-09-08 | 1,219 | $111.88 | $136.4K | 720,867 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-08 | 2026-09-08 | 9,681 | $112.28 | $1.09M | 730,548 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-08 | 2026-09-08 | 500 | $108.24 | $54.1K | 719,648 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-08 | 2026-09-08 | 9,681 | $112.28 | $1.09M | 730,548 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-08 | 2026-09-08 | 1,219 | $111.88 | $136.4K | 720,867 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-08 | 2026-09-08 | 500 | $108.23 | $54.1K | 719,648 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-08 | 2026-09-08 | 1,100 | $107.12 | $117.8K | 719,148 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-08 | 2026-09-08 | 6,605 | $100.64 | $664.7K | 718,048 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2026-09-08 | 2026-09-08 | 5,895 | $99.29 | $585.3K | 711,443 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2024-09-16 | 2024-09-16 | 13,037 | $17.13 | $223.3K | 705,548 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2024-09-12 | 2024-09-16 | 26,963 | $15.05 | $405.8K | 692,511 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2024-09-10 | 2024-09-10 | 8,500 | $15.19 | $129.1K | 665,548 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2024-09-09 | 2024-09-10 | 9,500 | $15.21 | $144.5K | 657,048 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2024-09-06 | 2024-09-10 | 26,000 | $15.29 | $397.5K | 647,548 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2024-09-03 | 2024-09-03 | 15,288 | $15.66 | $239.4K | 160,288 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2024-09-03 | 2024-09-03 | 4,712 | $16.31 | $76.9K | 165,000 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2024-08-30 | 2024-09-03 | 10,000 | $14.02 | $140.2K | 145,000 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2024-08-29 | 2024-09-03 | 10,000 | $14.03 | $140.3K | 135,000 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2024-08-21 | 2024-08-22 | 12,945 | $12.93 | $167.4K | 54,865 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2024-08-20 | 2024-08-22 | 27,055 | $12.97 | $350.9K | 41,920 | SEC↗ |
| INXB Inhibrx Biosciences, Inc. | A Award deriv | 2024-05-30 | 2024-05-30 | 300,000 | — | $0 | 300,000 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer deriv | 2024-05-30 | 2024-05-30 | 100,000 | — | $0 | 0 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer deriv | 2024-05-30 | 2024-05-30 | 145,000 | — | $0 | 0 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer | 2024-05-30 | 2024-05-30 | 2,486,192 | $30.00 | $74.59M | 0 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer | 2024-05-30 | 2024-05-30 | 59,462 | $30.00 | $1.78M | 0 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer | 2024-05-30 | 2024-05-30 | 500,000 | $30.00 | $15.00M | 0 | SEC↗ |
| INXB Inhibrx Biosciences, Inc. | A Award | 2024-05-29 | 2024-05-30 | 621,548 | — | $0 | 621,548 | SEC↗ |
| INXB Inhibrx Biosciences, Inc. | A Award | 2024-05-29 | 2024-05-30 | 125,000 | — | $0 | 125,000 | SEC↗ |
| INXB Inhibrx Biosciences, Inc. | A Award | 2024-05-29 | 2024-05-30 | 14,865 | — | $0 | 14,865 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2023-02-28 | 2023-03-01 | 60 | $25.02 | $1.5K | 2,486,192 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2023-01-24 | 2023-01-24 | 4,272 | $25.71 | $109.8K | 2,486,315 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2023-01-24 | 2023-01-24 | 63 | $26.11 | $1.6K | 2,486,252 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2023-01-23 | 2023-01-24 | 21,665 | $25.36 | $549.4K | 2,490,587 | SEC↗ |
| INBX Inhibrx, Inc. | A Award deriv | 2023-01-03 | 2023-01-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-12-19 | 2022-12-20 | 25,246 | $25.53 | $644.5K | 2,513,006 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-12-19 | 2022-12-20 | 754 | $26.29 | $19.8K | 2,512,252 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-11-17 | 2022-11-18 | 4,333 | $27.45 | $118.9K | 2,548,854 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-11-17 | 2022-11-18 | 1,767 | $28.86 | $51.0K | 2,547,087 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-11-17 | 2022-11-18 | 912 | $30.67 | $28.0K | 2,539,402 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-11-17 | 2022-11-18 | 1,150 | $32.38 | $37.2K | 2,538,252 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-11-17 | 2022-11-18 | 4,106 | $26.57 | $109.1K | 2,553,187 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-11-17 | 2022-11-18 | 6,773 | $30.15 | $204.2K | 2,540,314 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-11-17 | 2022-11-18 | 6,959 | $25.36 | $176.5K | 2,557,293 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-10-17 | 2022-10-18 | 2,892 | $30.81 | $89.1K | 2,564,373 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-10-17 | 2022-10-18 | 8,981 | $28.66 | $257.4K | 2,581,271 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-10-17 | 2022-10-18 | 121 | $31.51 | $3.8K | 2,564,252 | SEC↗ |
| INBX Inhibrx, Inc. | S Sale | 2022-10-17 | 2022-10-18 | 14,006 | $29.92 | $419.1K | 2,567,265 | SEC↗ |
| INBX Inhibrx, Inc. | A Award deriv | 2021-01-15 | 2021-01-19 | 145,000 | — | $0 | 145,000 | SEC↗ |
| INBX Inhibrx, Inc. | G Gift | 2020-12-28 | 2021-01-19 | 500,000 | — | $0 | 500,000 | SEC↗ |
| INBX Inhibrx, Inc. | G Gift | 2020-12-28 | 2021-01-19 | 500,000 | — | $0 | 2,590,252 | SEC↗ |